SOAT1 and heart failure: Moreover, since pre-existing AF could aggravate the symptoms of COVID-19 infection, inspired by antibiotic pretreatment, we believe that on the premise of ensuring safety and drug compatibility, the use of STAT inhibitors in advance for AF patients in an infection-risk environment might provide potential clinical benefits for the risk of inflammatory cardiac dysfunction (AF, ventricular fibrillation, heart failure, etc.).